Gestational toxoplasmosis treatment changes the child's prognosis: A cohort study in southern Brazil.

ABSTRACT:

Background

We evaluate the drug treatment for pregnant women with acute toxoplasmosis to reduce the risk of congenital infection, side effects (prenatal and postnatal treatment in children) and the hazard of discontinuing the infant's medication.

Methods

We conducted a prospective cohort study to assess the risks of congenital toxoplasmosis among children born to acutely infected women with and without treatment. We examined the relationship between "exposed" and "infected children", "number of infant neutrophils", "prenatal" and "postnatal treatment". Factor analysis of mixed data (FAMD) was used to analyze the data. All children started treatment at the hospital.

Findings

Between 2017 and 2021, 233 pregnant women were evaluated at the University Hospital of Maringá;

SUBMITTER: Gomes Ferrari Strang AG 

PROVIDER: S-EPMC10593203 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature